These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 8530741

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Biochemical composition of the connective tissue in keloids and analysis of collagen metabolism in keloid fibroblast cultures.
    Abergel RP, Pizzurro D, Meeker CA, Lask G, Matsuoka LY, Minor RR, Chu ML, Uitto J.
    J Invest Dermatol; 1985 May; 84(5):384-90. PubMed ID: 3998489
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of arecoline, safrole, and nicotine on collagen phagocytosis by human buccal mucosal fibroblasts as a possible mechanism for oral submucous fibrosis in Taiwan.
    Shieh DH, Chiang LC, Lee CH, Yang YH, Shieh TY.
    J Oral Pathol Med; 2004 Oct; 33(9):581-7. PubMed ID: 15357680
    [Abstract] [Full Text] [Related]

  • 6. Collagen gene expression in human dental pulp cell cultures.
    Kuo MY, Lan WH, Lin SK, Tsai KS, Hahn LJ.
    Arch Oral Biol; 1992 Nov; 37(11):945-52. PubMed ID: 1281629
    [Abstract] [Full Text] [Related]

  • 7. Collagen gene expression in keloids: analysis of collagen metabolism and type I, III, IV, and V procollagen mRNAs in keloid tissue and keloid fibroblast cultures.
    Ala-Kokko L, Rintala A, Savolainen ER.
    J Invest Dermatol; 1987 Sep; 89(3):238-44. PubMed ID: 3624897
    [Abstract] [Full Text] [Related]

  • 8. Distribution of procollagen type III, collagen type VI and tenascin in oral submucous fibrosis (OSF).
    Reichart PA, van Wyk CW, Becker J, Schuppan D.
    J Oral Pathol Med; 1994 Oct; 23(9):394-8. PubMed ID: 7529836
    [Abstract] [Full Text] [Related]

  • 9. Deficiency in collagen and fibronectin phagocytosis by human buccal mucosa fibroblasts in vitro as a possible mechanism for oral submucous fibrosis.
    Tsai CC, Ma RH, Shieh TY.
    J Oral Pathol Med; 1999 Feb; 28(2):59-63. PubMed ID: 9950251
    [Abstract] [Full Text] [Related]

  • 10. The fibroblast population in oral submucous fibrosis.
    de Waal J, Olivier A, van Wyk CW, Maritz JS.
    J Oral Pathol Med; 1997 Feb; 26(2):69-74. PubMed ID: 9049905
    [Abstract] [Full Text] [Related]

  • 11. Hypoxic regulation of plasminogen activator inhibitor-1 expression in human buccal mucosa fibroblasts stimulated with arecoline.
    Tsai CH, Lee SS, Chang YC.
    J Oral Pathol Med; 2015 Oct; 44(9):669-73. PubMed ID: 25367145
    [Abstract] [Full Text] [Related]

  • 12. Collagen gene expression by cultured human skin fibroblasts. Abundant steady-state levels of type VI procollagen messenger RNAs.
    Olsen DR, Peltonen J, Jaakkola S, Chu ML, Uitto J.
    J Clin Invest; 1989 Mar; 83(3):791-5. PubMed ID: 2921321
    [Abstract] [Full Text] [Related]

  • 13. Increased collagen biosynthesis and increased expression of type I and type III procollagen genes in tight skin (TSK) mouse fibroblasts.
    Jimenez SA, Williams CJ, Myers JC, Bashey RI.
    J Biol Chem; 1986 Jan 15; 261(2):657-62. PubMed ID: 2416757
    [Abstract] [Full Text] [Related]

  • 14. Immunolocalization of cytokines and growth factors in oral submucous fibrosis.
    Haque MF, Harris M, Meghji S, Barrett AW.
    Cytokine; 1998 Sep 15; 10(9):713-9. PubMed ID: 9770333
    [Abstract] [Full Text] [Related]

  • 15. Characterization of type II and type XI collagen synthesis by an immortalized rat chondrocyte cell line (IRC) having a low level of type II collagen mRNA expression.
    Oxford JT, Doege KJ, Horton WE, Morris NP.
    Exp Cell Res; 1994 Jul 15; 213(1):28-36. PubMed ID: 8020600
    [Abstract] [Full Text] [Related]

  • 16. Coordinated regulation of type I and type III collagen production and mRNA levels of pro alpha 1(I) and pro alpha 2(I) collagen in cultured morphea fibroblasts.
    Vuorio T, Mäkelä JK, Kähäri VM, Vuorio E.
    Arch Dermatol Res; 1987 Jul 15; 279(3):154-60. PubMed ID: 3592743
    [Abstract] [Full Text] [Related]

  • 17. Extracellular matrix remodeling in oral submucous fibrosis: its stage-specific modes revealed by immunohistochemistry and in situ hybridization.
    Utsunomiya H, Tilakaratne WM, Oshiro K, Maruyama S, Suzuki M, Ida-Yonemochi H, Cheng J, Saku T.
    J Oral Pathol Med; 2005 Sep 15; 34(8):498-507. PubMed ID: 16091118
    [Abstract] [Full Text] [Related]

  • 18. Elevated expression of NF-kappaB in oral submucous fibrosis--evidence for NF-kappaB induction by safrole in human buccal mucosal fibroblasts.
    Ni WF, Tsai CH, Yang SF, Chang YC.
    Oral Oncol; 2007 Jul 15; 43(6):557-62. PubMed ID: 16996785
    [Abstract] [Full Text] [Related]

  • 19. Modulation of procollagen gene expression by retinoids. Inhibition of collagen production by retinoic acid accompanied by reduced type I procollagen messenger ribonucleic acid levels in human skin fibroblast cultures.
    Oikarinen H, Oikarinen AI, Tan EM, Abergel RP, Meeker CA, Chu ML, Prockop DJ, Uitto J.
    J Clin Invest; 1985 May 15; 75(5):1545-53. PubMed ID: 2987306
    [Abstract] [Full Text] [Related]

  • 20. The upregulation of type I plasminogen activator inhibitor in oral submucous fibrosis.
    Yang SF, Hsieh YS, Tsai CH, Chou MY, Chang YC.
    Oral Oncol; 2003 Jun 15; 39(4):367-72. PubMed ID: 12676256
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.